期刊
JOURNAL OF SURGICAL ONCOLOGY
卷 103, 期 5, 页码 451-459出版社
WILEY
DOI: 10.1002/jso.21831
关键词
screening and diagnosis; personalized cancer care; tumorigenesis
Metabolomics, the newest of the omics sciences, has brought much excitement to the field of oncology as a potential new translational tool capable of bringing the molecular world of cancer care to the bedside. While still early in its development, metabolomics could alter the scope and role of surgery in the multidisciplinary treatment of cancer. This review examines potential roles of metabolomics in areas of early cancer detection, personalized therapeutics and tumorigenesis J. Surg. Oncol. 2011; 103: 451-459. (C) 2010 Wiley-Liss, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据